Isis Pharmaceuticals, Inc. · Carlsbad, CA United States ·(NASDAQ (GM): ISIS)
Company Description
View Isis Pharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Isis Pharmaceuticals is trying to make sense out of antisense. The biotechnology company is developing drug therapies based on antisense technology, in which drugs attach themselves to strands of RNA in order to prevent them from producing disease-causing proteins; the hoped-for end result is a therapy that fights disease without harming healthy cells. Isis Pharmaceuticals works by discovering potential compounds (primarily in the areas of cardiovascular and metabolic disease but also in a range of other categories) and finding larger pharmaceutical partners to license the drugs or collaborate in their development. Its lead candidate is high cholesterol drug mipomersen, which Isis has licensed to Genzyme .
To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Isis Pharmaceuticals, Inc. Financials
| Company Type | Public - NASDAQ (GM): ISIS Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $107.2 |
| 2008 Employees | 300 |
Isis Pharmaceuticals, Inc. Executives
24 executives listed for Isis Pharmaceuticals, Inc.'s Carlsbad, CA location.
| Title | Name & Bio | Contact |
| Chairman, President, and CEO | Stanley Crooke | Network |
| COO, CFO, Secretary, and Director | B. Lynne Parshall | Network |
| VP and Chief Medical Officer | Walter Singleton | Network |
Competition
Competitive Landscape for Isis Pharmaceuticals, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Isis Pharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!